Jaye Thompson insider trades

Open-market stock purchases and sales by Jaye Thompson, VP Clinical Reg Affairs at Greenwich LifeSciences, Inc, from SEC Form 4 filings since May 17, 2010.

Track record: 100% of 21 scored buys are up 5% or more since purchase, averaging +61%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • GLSI Greenwich LifeSciences, Inc: 21 buys, last Dec 24, 2024
  • RPRX Repros Therapeutics Inc: other filings, last Jul 5, 2016
  • OPXA Opexa Therapeutics, Inc: other filings, last Sep 12, 2012

Get free alerts when Jaye Thompson files a new trade →